MENU

Is the BWX Ltd (ASX:BWX) share price in the buy zone?

Source: Company presentation

Personal care product manufacturer and distributor BWX Ltd’s (ASX: BWX) share price has fallen 13% since the release of a trading update on October 29.

Why has the BWX share price fallen?

The trading update revealed that the company expects normalised FY19 earnings before interest, tax, depreciation and amortisation (EBITDA) to be flat at $40.3 million. This disappointed the market as it had priced in a higher amount factoring in the first full-year contributions from the 2017 acquisitions of Andalou Naturals and Nourished Life.

Furthermore, the trading update also noted that BWX expects a 70% EBITDA skew to the second half. In other words, first-half EBITDA for FY19 is projected to be around $12 million. This would represent a fall of about 31% over the first half of FY18. When you factor in that the contributions of Andalou and Nourished Life were for 2 and 3 months respectively in the first half of FY18, the deterioration in earnings is even larger. The decline in first-half earnings has been attributed to the impact from the company’s change programs, platform improvement processes and the failed management buyout.

Can BWX turn this around?

In order for BWX to hit its EBITDA target of $40 million, second half EBITDA would have to grow by 24% over the prior corresponding period. The market appears skeptical on whether BWX can hit this target which has been reflected in the sell-off subsequent to the release of the trading update.

The market has also raised concerns regarding BWX’s flagship brand and highest margin segment Sukin. Although Sukin delivered organic growth of 6.1% in FY18 following the ongoing international expansion and its entrance into the domestic grocery channel via the Wesfarmers Ltd (ASX: WES) owned Coles, the growth was skewed towards the first half. Revenue for Sukin in the second half of FY18 fell 19% over the first half and was down 5% compared to the second half of FY17.

Foolish takeaway

The consensus earnings per share estimate for FY19 has fallen to 20.04 cents today from 25.06 cents a month ago. This is lower than the 21.5 cents of underlying earnings the company generated in FY18. At current prices, the stock is trading at a forward valuation of 14 times earnings.

The failed management buyout, slowing growth from Sukin and underperformance relative to acquisition forecasts of Mineral Fusion and Nourished Life has seen BWX fall out of favour after being one of the market’s growth darlings in 2017.

If the company can turn around its fortunes then today’s price represents good value. FY20 estimated earnings for BWX are currently 25.75 cents, which prices the stock at only 11 times earnings. However, given the company’s recent track record in not meeting earnings expectations, it might be reasonable to hold off from opening a position until BWX reports its half-yearly in February. The report should provide some clarity on whether the company’s new management team has turned around the business and whether it can return to growth.

In the meantime, investors may want to consider other beaten down shares such as A2 Milk Company Ltd (ASX: A2M) and Bellamy’s Australia Ltd (ASX: BAL).

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor Tim Katavic has no financial interest in any company mentioned. The Motley Fool Australia owns shares of and has recommended BWX Limited and Wesfarmers Limited. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.